Pharmacodynamic Evaluation of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 30 Oct 2017
At a glance
- Drugs Clopidogrel (Primary) ; Ticagrelor
- Indications Coronary artery disease
- Focus Pharmacodynamics
- Acronyms SWAP-4
- 25 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 15 Mar 2017 Planned End Date changed from 1 Aug 2017 to 1 Feb 2018.
- 15 Mar 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.